You searched "Mochi Health reviews" because you saw the $99 per month compounded semaglutide price and wondered if it was real. It is real. But it requires a separate $79 per month membership, bringing your true minimum to $178 per month. That distinction between the advertised medication price and the total out-of-pocket cost is the single most important detail in any Mochi Health review.
Mochi Health is a legitimate telehealth obesity clinic based in San Francisco. It holds a 4.4 out of 5 Trustpilot rating across more than 14,000 reviews, partners with licensed compounding pharmacies, and provides live 30-minute video consultations with board-certified physicians. It also has a BBB complaint pattern and documented billing frustrations. Both realities coexist.
| Detail | Information |
|---|---|
| Company | Mochi Health (joinmochi.com) |
| Founded | 2022, San Francisco, CA |
| Type | Telehealth obesity medicine clinic |
| Medications | Compounded semaglutide, compounded tirzepatide, brand-name Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda, Victoza |
| Membership | $79/mo (standard) or $69/mo (Wellness Plus with insurance) |
| Compounded Semaglutide | $99/mo (all doses) |
| Compounded Tirzepatide | $199/mo (all doses) |
| Trustpilot | 4.4/5 (14,000+ reviews) |
| BBB | Not rated; complaint pattern noted |
| Consultations | Live 30-min video visits |
| Insurance | Wellness Plus plan accepts qualifying insurance |
This review covers everything: pricing math, what real patients report, the regulatory landscape for compounded GLP-1 medications, and how Mochi stacks up against Hims, Ro, and other telehealth weight loss platforms. If you are comparing providers for semaglutide or tirzepatide, this is the breakdown you need.
Get your custom peptide protocol:
- Tailored to your body and goals
- Precise dosing and cycle length
- Safe stacking combinations
- Backed by peer-reviewed studies
- Ready in under 2 minutes
What Is Mochi Health?
Mochi Health is a telehealth platform specializing in obesity medicine. Unlike platforms that route you through asynchronous questionnaires reviewed by invisible providers, Mochi builds its model around live video visits. Every patient starts with a 30-minute consultation with a board-certified physician or nurse practitioner. That provider reviews your medical history, discusses treatment options in real time, and builds a personalized plan before writing any prescription.
The company launched in 2022 and has scaled quickly. It operates nationwide, prescribes both compounded and brand-name GLP-1 medications, and pairs medical treatment with registered dietitian support. The app handles scheduling, messaging, prescription tracking, and progress monitoring.
A key structural detail: Mochi partners with Aequita Pharmacy for compounded medications. Compounded semaglutide and tirzepatide use the same active ingredients as brand-name drugs but are prepared by licensed compounding pharmacies rather than the original manufacturers. They are not FDA-approved products. This is standard across the telehealth weight loss industry.
Mochi also offers brand-name GLP-1 injections: Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda, and Victoza. Brand-name options require insurance coverage or out-of-pocket payment at retail pricing. Most patients choose the compounded route for cost reasons.
How Mochi Health Works
The process moves faster than most telehealth competitors. Four steps from signup to medication in hand.
Step 1: Online Health Questionnaire. You complete a detailed intake covering your medical history, current medications, allergies, BMI, and weight loss goals. This takes roughly 10 minutes.
Step 2: Live Video Consultation. Unlike Hims or Ro, which often rely on asynchronous provider review, Mochi schedules a live 30-minute video visit. Your provider asks questions, explains treatment options, and determines whether GLP-1 therapy is appropriate. This is the platform's strongest differentiator.
Step 3: Prescription and Pharmacy. If eligible, your provider prescribes a GLP-1 medication. For compounded options, the prescription goes to Aequita Pharmacy. Brand-name prescriptions route through standard pharmacy channels. For an overview of how to obtain these medications through various channels, see our guide on how to get semaglutide.
Step 4: Delivery and Ongoing Care. Compounded medications ship directly to your door in temperature-controlled packaging. Most patients receive their first shipment within one to two weeks of approval. Ongoing care includes follow-up video visits, 24/7 messaging with your care team, and access to a registered dietitian.
The live video model means you can ask questions about side effects, dosing adjustments, and treatment expectations in real time. Patients who have tried asynchronous platforms consistently cite this as the reason they switched to Mochi.
Mochi Health Pricing Breakdown
Mochi uses a membership-plus-medication pricing model. The membership covers provider access, consultations, dietitian support, and ongoing monitoring. Medication costs are separate. Understanding this split is essential before you sign up.
Standard Membership: $79 per Month
The base membership includes:
- Regular video visits with a physician or nurse practitioner
- Registered dietitian consultations
- 24/7 messaging with your care team
- Progress monitoring and dose adjustments
- Access to labs, genetic testing, and sleep apnea assessments when clinically indicated
This fee applies regardless of which medication you choose. It is billed monthly and is separate from your medication cost.
Wellness Plus Membership: $69 per Month
If you have qualifying health insurance, Mochi's Wellness Plus plan reduces the membership to $69 per month and adds advanced nutrition therapy, mental health support, and expanded health services. Mochi guarantees $0 in surprise bills, no copays, and no deductibles on the Wellness Plus plan.
The catch: your insurance must be on their qualifying list. Mochi does not accept insurance for medication costs, only for the enhanced membership services.
Medication Pricing
| Medication | Format | Monthly Cost | Total with Membership |
|---|---|---|---|
| Compounded semaglutide | Weekly injection | $99 | $178/mo |
| Compounded GLP-1/GIP (tirzepatide) | Weekly injection | $199 | $278/mo |
| Brand-name Wegovy | Weekly injection | Insurance or ~$1,350+/mo | $1,429+/mo |
| Brand-name Mounjaro | Weekly injection | Insurance or ~$1,100+/mo | $1,179+/mo |
| Brand-name Zepbound | Weekly injection | Insurance or ~$1,100+/mo | $1,179+/mo |
Prices verified April 2026. Compounded medication prices are flat across all dose levels. Whether you are on a starting dose or the maximum dose, the price stays the same.
The $99 compounded semaglutide is genuinely one of the lowest prices in the telehealth weight loss market. But always calculate the total: $99 medication plus $79 membership equals $178 per month, or $2,136 per year. For a broader look at semaglutide costs across providers, see our semaglutide pricing guide. You can also estimate your specific costs with our peptide cost calculator.
True Annual Cost
Mochi bills monthly. Assuming consistent enrollment and no plan changes:
| Medication | Monthly Total | Annual Cost |
|---|---|---|
| Compounded semaglutide | $178 | $2,136 |
| Compounded tirzepatide | $278 | $3,336 |
These totals assume the standard $79 membership. Wellness Plus members pay $69 per month for membership, reducing annual totals by $120.
Compared to brand-name GLP-1 medications at retail price ($13,000 to $16,000 per year for Wegovy or Mounjaro without insurance), Mochi's compounded options represent substantial savings. The tradeoff is that compounded medications are not FDA-approved and carry the caveats discussed in the safety section below.
Medications Available Through Mochi Health
Mochi offers one of the broadest medication selections among telehealth weight loss platforms. Most competitors offer compounded semaglutide only. Mochi provides compounded and brand-name options for both major GLP-1 drug classes.
Compounded GLP-1 (Semaglutide)
Compounded semaglutide is the most popular option. It contains the same active ingredient found in Ozempic and Wegovy but is prepared by a licensed compounding pharmacy. At $99 per month for all dose levels, it is the entry-level choice for most patients.
Clinical trials for semaglutide showed 10% to 14% body weight loss when paired with diet and exercise over 68 weeks. Compounded versions use the same active molecule but have not undergone separate bioequivalence testing. For an in-depth look at semaglutide before and after results, see our patient outcomes guide.
Many compounding pharmacies add vitamin B12 to their semaglutide formulations. Mochi's partner pharmacy follows this practice. For details on what this addition means, read our compounded semaglutide with B12 analysis.
Compounded GLP-1/GIP (Tirzepatide)
Compounded tirzepatide targets both GLP-1 and GIP receptors, a dual-agonist approach that produced up to 22.5% body weight loss in clinical trials. At $199 per month, it is pricier than compounded semaglutide but still a fraction of brand-name Mounjaro or Zepbound.
Tirzepatide is the stronger option for patients who have plateaued on semaglutide or who need more aggressive weight loss. If you are weighing the two medications, our tirzepatide profile covers the clinical data in detail. Use our semaglutide dosage calculator or tirzepatide dosage calculator to map out your escalation schedule.
Brand-Name Options
Mochi also prescribes FDA-approved brand-name GLP-1 medications: Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda, and Victoza. These require insurance coverage or cash payment at retail pricing.
If your insurance covers brand-name GLP-1 drugs, using Mochi's platform to access them through a live video consultation may be worthwhile. The $79 membership gets you ongoing provider access, dietitian support, and care coordination. For patients with good insurance, this can be more cost-effective than compounded alternatives once you factor in copay assistance programs.
Compounding Safety Context
Compounded GLP-1 medications are not FDA-approved products. They are prepared by licensed pharmacies under a doctor's prescription using the same active ingredients as brand-name drugs, but the final formulations have not undergone FDA review for safety, efficacy, or bioequivalence.
The FDA reported 605 adverse events linked to compounded semaglutide and 545 linked to compounded tirzepatide as of July 31, 2025. These include dosing errors, contamination, and reactions to inactive ingredients not present in brand-name versions.
Mochi's partner pharmacy, Aequita, is a licensed facility. Patients should request a Certificate of Analysis for their specific medication batch. This document confirms potency, sterility, and absence of contaminants. For a thorough examination of compounding risks, see our guide on compounded tirzepatide safety.
GLP-1 Side Effects on Mochi Health
The side effects patients experience on Mochi are not platform-specific. They are the same side effects documented in GLP-1 clinical trials, regardless of whether the medication is compounded or brand-name. The active ingredients are identical.
Common Side Effects
| Side Effect | Incidence (Clinical Trials) |
|---|---|
| Nausea | 40-44% |
| Diarrhea | 29-33% |
| Vomiting | 24-25% |
| Constipation | 21-24% |
| Injection site reaction | 5-10% |
These effects are dose-dependent. They peak during the first 4 to 8 weeks of treatment and during dose escalations. Slow titration reduces severity. Most patients find that nausea diminishes substantially after the body adjusts.
Mochi's live video consultation model gives patients a direct line to their provider for dosage adjustments. If nausea becomes unmanageable, your doctor can slow the escalation schedule or adjust the formulation. For evidence-based management strategies, see our guide on semaglutide and nausea.
What Mochi Patients Report
Reddit discussions and Trustpilot reviews from Mochi patients echo the clinical trial data. The most frequent complaint is nausea during the first month, particularly among patients who start at higher doses rather than titrating up gradually.
Positive reports focus on appetite suppression taking effect within the first week, steady weight loss of 1 to 2 pounds per week once at therapeutic dose, and provider willingness to adjust dosing based on individual tolerance.
A smaller subset of patients report fatigue and constipation during the first two weeks. These effects typically resolve without intervention. For patients exploring the full spectrum of weight loss peptides, our guide on best peptides for weight loss provides broader context beyond GLP-1 medications alone.
Trust and Transparency Analysis
Mochi's trust profile splits into clear strengths and documented concerns. Neither side tells the full story alone.
What Checks Out
Trustpilot: 4.4 out of 5 across 14,000+ reviews. Approximately 79% of reviewers gave five stars. The volume is substantial and the rating is above average for telehealth weight loss platforms. Positive reviews consistently cite three things: the live video consultation experience, responsive customer support, and effective weight loss results on the medication.
Live provider consultations. Mochi's 30-minute video visit model is a genuine differentiator. Most competitors (Hims, Ro, Henry Meds) rely on asynchronous review where a provider reads your questionnaire and makes a decision without a live conversation. Mochi puts you face-to-face with a doctor who can answer questions in real time.
Registered dietitian access. The membership includes nutrition counseling, not just medication. This matters because GLP-1 medications work best when paired with dietary changes. Access to a dietitian within the same platform reduces friction.
Broad medication selection. Six brand-name GLP-1 medications plus two compounded options gives patients and providers more flexibility than most competitors offer. If semaglutide is not working, your provider can switch you to tirzepatide or a brand-name alternative without changing platforms.
What Raises Questions
BBB complaint pattern. Mochi is not BBB-rated, but the Better Business Bureau has noted a pattern of complaints. Specific issues documented include patients charged for medication they never received, difficulty obtaining refunds after cancellation, and wrong doses shipped without resolution.
Shipping delays. A recurring theme across Reddit, Facebook groups, and consumer review sites is delayed medication shipments from Aequita, Mochi's partner compounding pharmacy. Some patients report waiting 2 to 3 weeks after payment before receiving medication. Others describe months-long gaps between shipments with slow customer service response.
Cancellation friction. Multiple patients report difficulty cancelling their membership through the app. Some describe being charged after cancellation, with the company refusing refunds and making it hard to remove payment information.
Billing cycle structure. Mochi bills monthly, but patients should verify the exact billing date and understand that medication and membership are billed separately. Unexpected charges are a common complaint across telehealth subscription models.
These issues do not make Mochi illegitimate. They represent operational growing pains common among rapidly scaling telehealth platforms. But they are worth knowing before you enter payment information.
What Real Patients Say
We reviewed Mochi Health feedback across Trustpilot, ConsumerAffairs, Reddit (r/Semaglutide, r/GLP1Agonists, r/Ozempic), Facebook groups, and independent review sites. The patterns are consistent.
Positive Feedback Patterns
The strongest praise clusters around three areas:
1. The consultation experience. Patients repeatedly describe their Mochi providers as knowledgeable, compassionate, and non-judgmental. The live video format builds a rapport that asynchronous questionnaire-based platforms cannot match. Several reviews specifically mention feeling heard for the first time in their weight loss journey.
2. Medication accessibility. For patients without insurance coverage for brand-name GLP-1 drugs, Mochi's $99 compounded semaglutide opens a door that was previously closed. Multiple patients describe trying and failing to get insurance authorization for Wegovy or Mounjaro before finding Mochi.
3. Weight loss results. Patients who receive and consistently take the medication report results consistent with clinical trial data: 10 to 15% body weight loss over 6 to 12 months on semaglutide, and up to 20%+ on tirzepatide. The medication works. That is not unique to Mochi; the active ingredients are the same across all platforms.
Common Complaints
The complaints cluster around operations, not medicine:
- Shipping delays from the partner pharmacy, sometimes extending to 2-3 weeks
- Difficulty adjusting doses or refill timing mid-cycle; changes often cannot take effect until the following month
- Cancellation requires contacting support directly rather than using a self-service option in the app
- Some patients report being sent the same dosage after requesting an increase
- Customer service response times vary; some patients describe quick resolutions while others describe weeks of follow-up
- The $79 membership fee is sometimes overlooked during signup, leading to higher-than-expected first charges
The complaint profile is operational, not clinical. Patients are generally satisfied with the medical care and provider quality. The friction points are in logistics, billing, and support response times.
The 2026 Regulatory Landscape
The legal foundation for compounded GLP-1 medications shifted in early 2026. This context directly affects every Mochi patient using compounded semaglutide or tirzepatide.
FDA Warning Letters and Shortage Resolution
The FDA sent 30 warning letters to GLP-1 compounders on February 20, 2026. The letters flagged specific violations: claims of "same active ingredients" as brand-name drugs, language implying therapeutic equivalence, and statements implying FDA approval.
These actions followed the resolution of both major GLP-1 drug shortages. The semaglutide shortage was resolved on February 21, 2025. The tirzepatide shortage was resolved on December 19, 2024. While drugs remain on the FDA shortage list, compounding pharmacies have broader legal authority to produce them. With shortages resolved, that authority narrows.
For a complete analysis of the regulatory changes and their implications, see our FDA peptide crackdown coverage.
The Hims/Novo Nordisk Settlement
On March 9, 2026, Novo Nordisk and Hims & Hers announced a settlement. Hims agreed to offer branded Novo Nordisk products through its platform and stop marketing compounded GLP-1 medications. This is significant: the largest telehealth weight loss platform is exiting compounding.
The settlement does not directly affect Mochi. But it establishes a precedent. If the biggest player exits compounding under legal pressure, smaller platforms face increased scrutiny. Mochi has not announced any changes to its compounding program as of April 2026.
What This Means for Mochi Patients
Mochi has not received an FDA warning letter as of April 2026. Its partnership with a licensed compounding pharmacy and its live consultation model provide some insulation. But the regulatory ground is shifting.
Current Mochi patients should monitor for changes in medication availability and pricing. If the FDA escalates enforcement against compounders broadly, compounded semaglutide and tirzepatide may become harder to obtain or more expensive. Brand-name options through Mochi would remain available but at significantly higher cost.
The practical advice: enjoy the $99 compounded semaglutide while it lasts, but build a contingency plan. Ask your Mochi provider about brand-name alternatives and check your insurance coverage for Wegovy, Ozempic, or Mounjaro.
Mochi Health vs. Competitors
| Provider | Semaglutide/mo | Tirzepatide/mo | Membership Fee | Live Video Visits | Trustpilot |
|---|---|---|---|---|---|
| Mochi Health | $99 + $79 mem = $178 | $199 + $79 mem = $278 | $79/mo | Yes (30 min) | 4.4/5 |
| Hims | $199+ | N/A (exiting compounding) | None | No (async) | 4.0/5 |
| Ro | $199+ | Varies | None | No (async) | 4.2/5 |
| Henry Meds | $197-$297 | Varies | None | No (async) | 4.1/5 |
| Zealthy | $151 + $135 mem = $286 | $216 + $135 mem = $351 | $135/mo | No (async) | 3.2/5 |
| MEDVi | $299 | $399 | None | No (async) | 4.4/5 |
Sources: Provider websites, verified April 2026.
Mochi vs. Hims
Hims uses an asynchronous, form-heavy process. A provider reviews your intake offline and makes a decision without a live conversation. Hims historically offered one of the lowest prices for compounded semaglutide. However, following its March 2026 settlement with Novo Nordisk, Hims is transitioning to branded products and exiting compounded GLP-1s.
Mochi's advantage: live video visits and continued access to compounded medications. Hims' advantage was price, but that advantage is disappearing as it pivots to brand-name products at higher price points.
Mochi vs. Ro
Ro offers online visits and an insurance concierge service. Its model is asynchronous: you complete a questionnaire, a provider reviews it, and you receive a decision. Ro includes some coaching elements and has a solid 4.2 Trustpilot rating.
Mochi's advantage: live video consultations and lower compounded medication pricing. Ro's advantage: broader insurance integration and a more established brand presence. If your insurance covers brand-name GLP-1 drugs, Ro's concierge model may save you more money long-term.
Mochi vs. Zealthy
Zealthy charges $135 per month for membership plus medication fees. Total cost for semaglutide through Zealthy reaches $286 per month, roughly $108 more than Mochi. Zealthy's Trustpilot rating sits at 3.2, considerably lower than Mochi's 4.4.
Mochi wins on both price and patient satisfaction in this comparison. The only scenario where Zealthy might be preferable is if Mochi is unavailable in your state.
The Bottom Line on Competitors
Mochi's combination of live video visits, $178 per month total for compounded semaglutide, and broad medication selection puts it in the top tier of telehealth weight loss platforms. Its operational issues (shipping delays, cancellation friction) are real but not unique to Mochi. Nearly every competitor in this space faces similar growing pains.
For a broader comparison of sourcing options including compounding pharmacies, see our 2026 buyer's guide.
Verification Checklist Before Signing Up
Complete these eight steps before entering payment information. They protect you from billing surprises, medication quality issues, and coverage gaps.
- 1.Confirm state availability. Mochi operates in most states but not all. Verify your state is covered before starting the intake questionnaire.
- 1.Calculate total cost upfront. Add the $79 membership to your medication cost. Compounded semaglutide totals $178 per month ($2,136 annually). Compounded tirzepatide totals $278 per month ($3,336 annually). Do not compare Mochi's $99 medication price to competitors' all-in prices.
- 1.Verify the compounding pharmacy. Ask Mochi for the pharmacy name and license number. Check it against the NABP (National Association of Boards of Pharmacy) database and your state board of pharmacy. Confirm whether it holds 503A or 503B registration.
- 1.Request a Certificate of Analysis. Ask for the CoA for your specific medication batch before your first injection. This confirms potency, sterility, and absence of contaminants. Legitimate pharmacies provide these on request.
- 1.Understand the cancellation process. There is no self-service cancel button in the app. Plan to contact support if you need to cancel, and do so before your next billing date to avoid charges.
- 1.Confirm cold-chain shipping. GLP-1 injectable medications require temperature-controlled shipping. Verify that your shipment will include cold packs and insulated packaging, particularly during summer months.
- 1.Check insurance for brand-name options. Before committing to compounded medications, check whether your insurance covers Wegovy, Mounjaro, or Zepbound. If it does, the brand-name route through Mochi or another platform may be more cost-effective and carries full FDA approval.
- 1.Review HSA/FSA eligibility. Mochi's compounded medications may be eligible for HSA or FSA payment. Confirm with your plan administrator.
Who Should Use Mochi Health
Mochi is a strong fit if you:
- Value live video consultations with a physician rather than asynchronous questionnaire review
- Want compounded GLP-1 medications at one of the lowest total price points in the market
- Prefer a platform that offers both semaglutide and tirzepatide in compounded and brand-name formats
- Want registered dietitian support included in your membership
- Are comfortable with compounded (non-FDA-approved) medications and understand the tradeoffs
Mochi is not ideal if you:
- Need insurance to fully cover your GLP-1 medication (Ro or Found may integrate better)
- Require guaranteed fast shipping with no delays (Mochi's partner pharmacy has documented lag times)
- Want a self-service cancellation option in the app
- Prefer brand-name FDA-approved medications exclusively (and have insurance to cover them)
- Need a single all-in price with no separate membership fee
The platform serves a specific patient: someone who wants affordable compounded GLP-1 medications with genuine physician oversight through live video, is willing to pay the $79 membership on top of the medication cost, and can tolerate occasional shipping delays. If that describes your situation, Mochi delivers strong clinical value at a competitive price.
Frequently Asked Questions
Is Mochi Health legit?
Mochi Health is a legitimate telehealth obesity clinic. It holds a 4.4 out of 5 Trustpilot rating across more than 14,000 reviews, provides live 30-minute video consultations with board-certified providers, and partners with a licensed compounding pharmacy. It also has BBB complaints related to billing and shipping. The medical care is real; the operational issues are documented but not unusual for a rapidly scaling telehealth platform. For more on sourcing legitimate semaglutide, see our provider comparison guides.
How much does Mochi Health cost per month?
The standard membership costs $79 per month. Compounded semaglutide adds $99 per month (total: $178). Compounded tirzepatide adds $199 per month (total: $278). Brand-name medications are available at retail pricing for patients with insurance. Annual cost for compounded semaglutide: $2,136. For compounded tirzepatide: $3,336. Use our peptide cost calculator to estimate your specific annual spend.
Does Mochi Health accept insurance?
Mochi's Wellness Plus plan ($69/mo membership) accepts qualifying insurance for enhanced services like nutrition therapy and mental health support. Insurance does not cover the compounded medication cost. If your insurance covers brand-name GLP-1 drugs like Wegovy or Mounjaro, Mochi can prescribe those through standard pharmacy channels. Check our guide on how to get semaglutide for all available pathways including insurance routes.
What medications does Mochi Health prescribe?
Mochi prescribes compounded semaglutide ($99/mo), compounded tirzepatide ($199/mo), and six brand-name GLP-1 medications: Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda, and Victoza. This is one of the broadest selections among telehealth weight loss platforms. Compounded versions use the same active ingredients as brand-name drugs but are prepared by licensed pharmacies and are not FDA-approved. See our semaglutide before and after guide for typical patient results on these medications.
How does Mochi Health compare to Hims for weight loss?
Mochi offers live 30-minute video visits; Hims uses asynchronous provider review. Mochi charges $178/mo total for compounded semaglutide; Hims started at $199+/mo but is exiting compounded GLP-1s after its March 2026 Novo Nordisk settlement. Mochi still offers both compounded semaglutide and tirzepatide. Hims is pivoting to brand-name products only. For patients who want compounded GLP-1 access with live physician consultations, Mochi currently offers a better value. Use our semaglutide dosage calculator to plan your dose escalation regardless of provider.
How long does Mochi Health take to ship medication?
Mochi states that most patients receive medication within one to two weeks of provider approval. However, patient reviews report variable experiences. Some receive shipments within a week; others describe delays of 2 to 3 weeks from the partner pharmacy. Shipping delays are the most common complaint in negative reviews. Temperature-controlled packaging is used for injectable medications.
Can I cancel Mochi Health anytime?
Mochi states there is no long-term commitment. However, there is no self-service cancel button in the app. Cancellation requires contacting customer support directly. Multiple patients have reported difficulty cancelling and being charged after requesting cancellation. Contact support before your next billing date and confirm cancellation in writing.
Is compounded semaglutide from Mochi Health safe?
Compounded semaglutide contains the same active ingredient as Ozempic and Wegovy but is not an FDA-approved product. Mochi's partner pharmacy is licensed, but compounded formulations have not undergone FDA review for bioequivalence. The FDA reported 605 adverse events for compounded semaglutide as of July 2025. Request a Certificate of Analysis for your batch. For a full safety analysis, see our guide on compounded semaglutide with B12.
What are common side effects of GLP-1 medications from Mochi?
Side effects are medication-dependent, not platform-dependent. Common GLP-1 side effects include nausea (40-44%), diarrhea (29-33%), vomiting (24-25%), and constipation (21-24%). These are dose-dependent and typically improve after 4 to 8 weeks. Mochi's live video model allows real-time dosage adjustments to manage side effects. For management strategies, see our guide on does semaglutide cause nausea.
Does Mochi Health offer tirzepatide?
Yes. Mochi offers compounded tirzepatide (labeled as GLP-1/GIP) at $199 per month plus the $79 membership ($278 total). It also offers brand-name Mounjaro and Zepbound through standard pharmacy channels for patients with insurance coverage. Tirzepatide produced up to 22.5% body weight loss in clinical trials, making it the more potent option for patients who have plateaued on semaglutide. Learn more about tirzepatide in our peptide profile.
The Bottom Line
Mochi Health delivers a genuinely differentiated experience in the crowded telehealth weight loss market. The live 30-minute video consultation sets it apart from the asynchronous questionnaire model that dominates the industry. The $178 per month total for compounded semaglutide (membership plus medication) is competitive. The $278 per month total for compounded tirzepatide undercuts most alternatives.
The trust profile is strong but not flawless. A 4.4 Trustpilot rating across 14,000+ reviews reflects broad patient satisfaction with the medical care. BBB complaints and documented shipping delays reflect operational challenges that have not been fully resolved. The 2026 regulatory shift, including FDA warning letters to compounders and the Hims/Novo Nordisk settlement, adds uncertainty to the compounded medication landscape. Mochi has not been directly affected, but the environment is tightening.
If you choose Mochi, complete the verification checklist above before paying. Calculate total costs including the membership fee. Request a Certificate of Analysis for your medication. Understand the cancellation process before you need it. The medication itself, compounded semaglutide or tirzepatide, contains the same active ingredients that produced 10 to 22% body weight loss in clinical trials.
For help planning your dose escalation, use our free semaglutide dosage calculator. For a complete overview of semaglutide dosing, see our dosage guide. And if you are still comparing providers, our reviews of MEDVi, Zealthy, and Ellie MD cover the competitive landscape.
Related Articles
Hims Weight Loss Reviews 2026: Pricing & Verdict
Hims weight loss review 2026: GLP-1 medications from $149/mo plus $149 membership. Branded Wegovy and Ozempic via Novo Nordisk partnership. Trustpilot 3.5/5. Full pricing, pros, cons, and Reddit sentiment.
Found Weight Loss Reviews 2026: Pricing & Verdict
Found weight loss review 2026: GLP-1 medications from $129/mo self-pay or $49/mo with insurance. Trustpilot 3.6/5 (280+ reviews). Pricing, medications, and honest verdict.
Ro Weight Loss Reviews 2026: Pricing, Meds & Verdict
Ro weight loss review 2026: Body membership $145/mo + medication from $149/mo. Trustpilot 3.7/5 (3,198 reviews). FDA-approved GLP-1s, insurance support, health coaching. Full pricing breakdown.
Henry Meds Reviews 2026: Pricing, Trust & Verdict
Henry Meds review 2026: compounded semaglutide from $149/mo, tirzepatide from $199/mo. Trustpilot 4.5/5 but BBB F rating, Eli Lilly lawsuit. Full pricing and red flags.